Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The SyNAPSe trial will study if giving intravenous (i.v.) progesterone within 8 hours of the
injury for a total of 120 hours to severe traumatic brain injury patients improves their
recovery.